Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Accurate RNA splicing is essential for gene expression and human health, yet predicting how DNA sequence variations affect ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
1d
Identification of new molecular markers for multiple myeloma paves path for more precise therapies
Researchers at Cima and Clinica Universidad de Navarra have identified new molecular mechanisms underlying multiple myeloma. This type of hematologic cancer, which affects the bone marrow, is ...
Researchers found that autistic and non-autistic people move their faces differently when expressing emotions like anger, happiness, and sadness. Autistic participants tended to rely on different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results